GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Baotou Dongbao Bio-Tech Co Ltd (SZSE:300239) » Definitions » Receivables Turnover

Baotou Dongbao Bio-Tech Co (SZSE:300239) Receivables Turnover : 1.46 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Baotou Dongbao Bio-Tech Co Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Baotou Dongbao Bio-Tech Co's Revenue for the three months ended in Mar. 2024 was ¥241.8 Mil. Baotou Dongbao Bio-Tech Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥165.1 Mil. Hence, Baotou Dongbao Bio-Tech Co's Receivables Turnover for the three months ended in Mar. 2024 was 1.46.


Baotou Dongbao Bio-Tech Co Receivables Turnover Historical Data

The historical data trend for Baotou Dongbao Bio-Tech Co's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baotou Dongbao Bio-Tech Co Receivables Turnover Chart

Baotou Dongbao Bio-Tech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.92 4.54 4.98 6.36 6.33

Baotou Dongbao Bio-Tech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.57 1.46 1.34 1.53 1.46

Competitive Comparison of Baotou Dongbao Bio-Tech Co's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Baotou Dongbao Bio-Tech Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baotou Dongbao Bio-Tech Co's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Baotou Dongbao Bio-Tech Co's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Baotou Dongbao Bio-Tech Co's Receivables Turnover falls into.



Baotou Dongbao Bio-Tech Co Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Baotou Dongbao Bio-Tech Co's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Receivables Turnover (A: Dec. 2023 )
=Revenue / Average Total Inventories
=Revenue (A: Dec. 2023 ) / ((Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count )
=974.512 / ((146.117 + 162.029) / 2 )
=974.512 / 154.073
=6.33

Baotou Dongbao Bio-Tech Co's Receivables Turnover for the quarter that ended in Mar. 2024 is calculated as

Receivables Turnover (Q: Mar. 2024 )
=Revenue / Average Total Inventories
=Revenue (Q: Mar. 2024 ) / ((Accounts Receivable (Q: Dec. 2023 ) + Accounts Receivable (Q: Mar. 2024 )) / count )
=241.779 / ((162.029 + 168.24) / 2 )
=241.779 / 165.1345
=1.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Baotou Dongbao Bio-Tech Co  (SZSE:300239) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Baotou Dongbao Bio-Tech Co Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Baotou Dongbao Bio-Tech Co's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Baotou Dongbao Bio-Tech Co (SZSE:300239) Business Description

Traded in Other Exchanges
N/A
Address
No. 46, Huanghe Street, Rare Earth High-tech Industrial Development Zone, Baotou, CHN, 014030
Baotou Dongbao Bio-Tech Co Ltd operates in pharmaceutical manufacturing industry. The products of the company include collage, photosensitive gelatin, medicinal gelatin, edible gelatin, and calcium hydrogen phosphate.
Executives
Wang Li Ping Directors, executives
Liu Fang Directors, Directors, and Executives
Jia Li Ming Executives
Yu Jian Hua Supervisors
Zhao Xiu Mei Executives
Wang Jun Director
Wang Fu Rong Director
He Zhi Xian Supervisors
Zhan Wei Executives

Baotou Dongbao Bio-Tech Co (SZSE:300239) Headlines

No Headlines